Evidence map›Paper›PMID 23313617›Full record

ArticleVaccine2013

Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.

Janny Westdijk, Patrick Koedam, Mario Barro, Benjamin P Steil, Nicolas Collin, Thomas S Vedvick, Wilfried A M Bakker, Peter van der Ley, Gideon Kersten

Abstract readComparative Study
In one paragraph

Article in Vaccine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Janny WestdijkInstitute for Translational Vaccinology, Antonie van Leeuwenhoeklaan 9, 3720 AL Bilthoven, The Netherlands. janny.westdijk@rivm.nl
Patrick Koedam
Mario Barro
Benjamin P Steil
Nicolas Collin
Thomas S Vedvick
Wilfried A M Bakker
Peter van der Ley
Gideon Kersten

Funding

A Novel Systemic and Mucosal Adjuvant for BiodefenseU01AI070976 · NIAID · GLOBAL VACCINES, INC. · PI JOHNSTON, ROBERT E. · 2006 to 2010
$6.3M
NIAID NIH HHS U01 AI070976NIAID NIH HHS U01-AI070976
6 · The paper itself

Abstract

Six different adjuvants, each in combination with inactivated polio vaccine (IPV) produced with attenuated Sabin strains (sIPV), were evaluated for their ability to enhance virus neutralizing antibody titres (VNTs) in the rat potency model. The increase of VNTs was on average 3-, 15-, 24-fold with adjuvants after one immunization (serotypes 1, 2, and 3, respectively). Also after a boost immunization the VNTs of adjuvanted sIPV were on average another 7-20-27 times higher than after two inoculations of sIPV without adjuvant. The results indicate that it is feasible to increase the potency of inactivated polio vaccines by using adjuvants.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, NeutralizingAntibodies, ViralNeutralization TestsPoliovirusPoliovirus Vaccine, InactivatedPoliovirus VaccinesRatsAdjuvants, ImmunologicAntibodies, NeutralizingAntibodies, ViralPoliovirus Vaccine, InactivatedPoliovirus Vaccines

Identifiers

PMID23313617
PMCPMC3570672

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.